After Hours Gainer
ANIX Anixa Biosciences4.80-0.33-6.4%
After Hours:5.53+0.73 (+15.2%)
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
PRNewswireThu, 11-Dec 6:02 PM
After Hours:6.48+1.68 (+35.0%)
ANIX Anixa Biosciences4.47-1.50 (-25.1%)
ANIX Anixa Biosciences4.45-0.05 (-1.1%)
Premarket Decliner
ANIX Anixa Biosciences6.79-0.18-2.6%
Premarket:5.07-1.72 (-25.3%)
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million
PRNewswireMon, 22-Mar 10:00 PM
Premarket Gainer
ANIX Anixa Biosciences2.99-0.15-4.8%
Premarket:3.67+0.68 (+22.7%)
Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing
PRNewswireMon, 14-Dec 9:00 AM